BN Business News
Add your company to Business Communicator →

Business · 13/12/2018

FDA Releases Final Guidance on Data Integrity and Compliance With Drug CGMP: Questions and Answers

The FDA has announced the availability of a final guidance to clarify the role of data integrity in current good manufacturing practice for drugs, following an increase in data integrity lapses in recent inspections, and to help firms implement effective strategies to manage their data integrity risks.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights